Koers Rejuvel Bio-Sciences, Inc. Other OTC
Aandelen
NUUU
US7594081074
Overige speciaalzaken
Omzet 2013 | 0,05 0,05 | Omzet 2014 | 0,09 0,09 | Marktkapitalisatie | 35,47 mln. 33,03 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | - 0 | Nettowinst (verlies) 2014 | - 0 | EV/omzet 2013 * | - |
Nettoschuld 2013 | 508K 473K | Nettoschuld 2014 | 388K 362K | EV/omzet 2014 | 381.073.627 x |
K/w-verhouding 2013 * |
-
| K/w-verhouding 2014 |
-190
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 31,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 79 | 14-10-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 79 | 14-10-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,59% | 31,22 mld. | |
-16,69% | 4,13 mld. | |
+5,33% | 3,8 mld. | |
-7,02% | 1,74 mld. | |
-2,61% | 1,6 mld. | |
-14,00% | 1,24 mld. | |
-21,91% | 1,08 mld. | |
-39,73% | 876 mln. | |
+4,85% | 652 mln. |